NCT01440114

Brief Summary

The propose of this study is to determine the effect of intravenous fentanyl prior the end of surgery on the incidence and severity of EA in pediatric patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 26, 2011

Completed
Last Updated

September 26, 2011

Status Verified

September 1, 2011

Enrollment Period

1.3 years

First QC Date

September 22, 2011

Last Update Submit

September 22, 2011

Conditions

Keywords

emergence agitationpediatric patientfentanylincidence of emergence agitationseverity of emergence agitationadverse outcome from intervention

Outcome Measures

Primary Outcomes (1)

  • the incidence of emergence agitation

    pt was observed since emerging from anesthesia up to 60 minutes

Secondary Outcomes (3)

  • severity of emergence agitation

    pt was observed since emerging from anesthesia up to 60 minutes

  • adverse effect from intravenous fentanyl prior the end of surgery

    pt was observed since emerging from anesthesia upto 60 minutes

  • post operative pain

    pt was observed since emerging from anesthesia up to 60 minutes

Study Arms (2)

fentanyl group

ACTIVE COMPARATOR

First arm: intervention group. Patient in this group received fentanyl 1 mcg/kg (concentration 10mcg/ml) intravenous route 15 minutes before the end of surgery.

Drug: fentanyl

controlled group

PLACEBO COMPARATOR

patient in this group received NSS 0.1 ml/kg 15 minutes before the end of surgery

Drug: NSS

Interventions

In intervention group patient received fentanyl 1 mcg/kg intravenous 15 minutes before the end of surgery.

fentanyl group
NSSDRUG

Patient in this group received NSS (0.1ml/kg)intravenous route 15 minutes before the end of surgery.

controlled group

Eligibility Criteria

Age2 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Aged between 2-9 years
  • IPD patient
  • Receiving Chloral hydrate 50mg/kg (BW\<20 kgs)or midazolam 0.1 mg /kg (BW\>20 kgs)Per oral for premedication
  • Scheduled for one kind of these surgeries; Otolaryngology, Ophthalmology, Urology, Orthopedic,General surgery, Plastic surgery and Cardiac catheterization.

You may not qualify if:

  • ASA physical status IV-V
  • History of drug allergy:thiopental, fentanyl cisatracurium, chloral hydrate and diazepam

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Prince of Songkla University

Hat Yai, Changwat Songkhla, 90110, Thailand

Location

MeSH Terms

Conditions

Psychomotor AgitationEmergence Delirium

Interventions

Fentanyl

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesPsychomotor DisordersNeurobehavioral ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAberrant Motor Behavior in DementiaBehavioral SymptomsBehaviorDeliriumConfusionPostoperative ComplicationsPathologic ProcessesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

September 22, 2011

First Posted

September 26, 2011

Study Start

March 1, 2010

Primary Completion

July 1, 2011

Study Completion

July 1, 2011

Last Updated

September 26, 2011

Record last verified: 2011-09

Locations